6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene

C32H32F2N6O2 — CID 123309551

IUPAC6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene
SMILESCC1CCC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC(COC(F)F)CN7)nc65)cc3-4)[nH]2)N1
InChIInChI=1S/C32H32F2N6O2/c1-16-2-6-25(37-16)30-36-13-27(39-30)19-3-5-21-20(9-19)15-41-28-11-22-18(10-23(21)28)4-7-24-29(22)40-31(38-24)26-8-17(12-35-26)14-42-32(33)34/h3-5,7,9-11,13,16-17,25-26,32,35,37H,2,6,8,12,14-15H2,1H3,(H,36,39)(H,38,40)
InChIKeyUESXDSIFUPFFPI-UHFFFAOYSA-N
MW570.64 g/mol
LogP6.37
Rot. Bonds6

About 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene

6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene (PubChem CID 123309551) has the molecular formula C32H32F2N6O2 and a molecular weight of 570.64 g/mol. Its IUPAC name is 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene.

Molecular Properties

Compound Name6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene
PubChem CID123309551
Molecular FormulaC32H32F2N6O2
Molecular Weight570.64 g/mol
Exact Mass570.26
IUPAC Name6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene
SMILESCC1CCC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC(COC(F)F)CN7)nc65)cc3-4)[nH]2)N1
InChIInChI=1S/C32H32F2N6O2/c1-16-2-6-25(37-16)30-36-13-27(39-30)19-3-5-21-20(9-19)15-41-28-11-22-18(10-23(21)28)4-7-24-29(22)40-31(38-24)26-8-17(12-35-26)14-42-32(33)34/h3-5,7,9-11,13,16-17,25-26,32,35,37H,2,6,8,12,14-15H2,1H3,(H,36,39)(H,38,40)
InChIKeyUESXDSIFUPFFPI-UHFFFAOYSA-N
XLogP6.37
TPSA99.88 Ų
H-Bond Donors4
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms42
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500570.64
LogP ≤ 56.37
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 106

Analyze 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene?
The IUPAC name of 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene (CID 123309551) is 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene.
What is the SMILES notation for 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene?
The canonical SMILES for 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene is CC1CCC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC(COC(F)F)CN7)nc65)cc3-4)[nH]2)N1.
What is the InChIKey of 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene?
The InChIKey is UESXDSIFUPFFPI-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H32F2N6O2/c1-16-2-6-25(37-16)30-36-13-27(39-30)19-3-5-21-20(9-19)15-41-28-11-22-18(10-23(21)28)4-7-24-29(22)40-31(38-24)26-8-17(12-35-26)14-42-32(33)34/h3-5,7,9-11,13,16-17,25-26,32,35,37H,2,6,8,12,14-15H2,1H3,(H,36,39)(H,38,40).
What are the key properties of 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene?
6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene has a molecular weight of 570.64 g/mol, XLogP of 6.37, 6 rotatable bonds, 4 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[4-(difluoromethoxymethyl)pyrrolidin-2-yl]-17-[2-(5-methylpyrrolidin-2-yl)-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaene is sourced from PubChem (CID 123309551), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).